Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$122.71 - $146.91 $3.51 Million - $4.2 Million
-28,600 Reduced 39.78%
43,300 $6.18 Million
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $7.34 Million - $9.77 Million
71,900 New
71,900 $9.23 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $2.05 Million - $4.49 Million
22,500 Added 300.0%
30,000 $2.73 Million
Q2 2023

Aug 11, 2023

BUY
$155.98 - $172.65 $1.17 Million - $1.29 Million
7,500 New
7,500 $1.21 Million
Q4 2022

Feb 10, 2023

BUY
$102.55 - $135.33 $492,240 - $649,584
4,800 Added 40.34%
16,700 $2.26 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $1.13 Million - $1.39 Million
11,900 New
11,900 $1.19 Million
Q4 2021

Feb 11, 2022

SELL
$95.88 - $117.08 $7.95 Million - $9.71 Million
-82,900 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$84.42 - $106.62 $1.82 Million - $2.29 Million
-21,500 Reduced 20.59%
82,900 $7.96 Million
Q2 2021

Aug 13, 2021

BUY
$67.66 - $84.76 $412,726 - $517,036
6,100 Added 6.21%
104,400 $8.75 Million
Q1 2021

May 14, 2021

SELL
$67.06 - $75.82 $3.39 Million - $3.84 Million
-50,600 Reduced 33.98%
98,300 $6.63 Million
Q4 2020

Feb 12, 2021

BUY
$63.89 - $73.8 $9.37 Million - $10.8 Million
146,600 Added 6373.91%
148,900 $10.4 Million
Q3 2020

Nov 13, 2020

SELL
$63.69 - $70.22 $121,011 - $133,418
-1,900 Reduced 45.24%
2,300 $159,000
Q2 2020

Aug 14, 2020

SELL
$58.54 - $67.94 $93,664 - $108,704
-1,600 Reduced 27.59%
4,200 $275,000
Q1 2020

May 14, 2020

SELL
$49.46 - $64.78 $455,032 - $595,976
-9,200 Reduced 61.33%
5,800 $349,000
Q3 2019

Nov 08, 2019

SELL
$47.54 - $53.43 $3.14 Million - $3.53 Million
-66,000 Reduced 81.48%
15,000 $776,000
Q2 2019

Aug 14, 2019

BUY
$46.79 - $52.47 $3.09 Million - $3.46 Million
66,000 Added 440.0%
81,000 $4.13 Million
Q1 2019

May 15, 2019

BUY
$46.36 - $52.63 $695,400 - $789,450
15,000 New
15,000 $785,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $273B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.